CARIBOU BIOSCIENCES I
2.7800
07-November-24 15:59:58
15 minutes delayed
Stocks
+0.0300
+1.09%
Today's range
2.3700 - 2.9995
ISIN
N/A
Source
NASDAQ
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
01 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports CB-010 ANTLER Phase 1 Trial Progress
12 Dec 2022 08:01:00 By Nasdaq GlobeNewswire
-
12 Dec 2022 08:00:01 By Nasdaq GlobeNewswire
-
29 Nov 2022 09:00:01 By Nasdaq GlobeNewswire
-
21 Nov 2022 09:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
08 Nov 2022 16:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
07 Nov 2022 16:05:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 09:00:01 By Nasdaq GlobeNewswire
-
18 Oct 2022 09:00:02 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
31 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
09 Aug 2022 16:00:00 By Nasdaq GlobeNewswire
-
01 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
16 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
12 May 2022 10:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors
11 May 2022 16:00:00 By Nasdaq GlobeNewswire
-
Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates
09 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
Caribou Biosciences to Present at Upcoming Investor Conference
03 May 2022 16:05:00 By Nasdaq GlobeNewswire
-
25 Apr 2022 16:05:00 By Nasdaq GlobeNewswire